Markus Schlaich is a German trained physician and a board-certified specialist in internal medicine and nephrology. In 2005, he was among the first physicians to be certified as “Hypertension Specialist” in Germany. A similar initiative has been brought forward by the European Society of Hypertension (ESH) and he has been nominated as a European Hypertension Specialist by the ESH in 2006. He has a strong clinical research background in hypertension, nephrology, and cardiovascular disease. He obtained his M.D. from the University of Freiburg and specialized in internal medicine, nephrology, and hypertension at the University of Erlangen-Nuremberg. After a three-year postdoctoral period at the Baker Heart Research Institute in Melbourne (from 2000 to 2003), he recently relocated to Australia. He currently heads the “Neurovascular Hypertension & Kidney Disease Laboratory” at the Baker Heart Research Institute and acts as the Director of the Baker Hypertension Network. He also holds an NHMRC RD Wright Clinical Research Fellowship and an academic appointment with the Department of Medicine of Monash University. His research focuses primarily on pathophysiological aspects of essential hypertension, including the role of the renin-angiotensin-aldosterone system, the L-arginine/nitric oxide pathway and the sympathetic nervous system, their interaction, and the involvement of the kidneys. He has published more than 80 articles in peer-reviewed journals and has received several awards including the International Young Investigator Prize for Clinical Science at the World Congress of Cardiology in 2002, the Servier Sympathetic Nervous System Research Grant of the European Society of Hypertension 2003 Award, and the “Dr. Adalbert Buding Award” for hypertension research from the German Hypertension Society in 2005.
Biography Updated on 21 April 2009